SI1000027T1 - Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it - Google Patents
Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing itInfo
- Publication number
- SI1000027T1 SI1000027T1 SI9830442T SI9830442T SI1000027T1 SI 1000027 T1 SI1000027 T1 SI 1000027T1 SI 9830442 T SI9830442 T SI 9830442T SI 9830442 T SI9830442 T SI 9830442T SI 1000027 T1 SI1000027 T1 SI 1000027T1
- Authority
- SI
- Slovenia
- Prior art keywords
- carbazolyloxy
- propanole
- methoxyphenoxy
- ethylamino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97112491A EP0893440A1 (en) | 1997-07-22 | 1997-07-22 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
PCT/EP1998/004475 WO1999005105A1 (en) | 1997-07-22 | 1998-07-18 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
EP98937576A EP1000027B1 (en) | 1997-07-22 | 1998-07-18 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1000027T1 true SI1000027T1 (en) | 2003-10-31 |
Family
ID=8227094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9830442T SI1000027T1 (en) | 1997-07-22 | 1998-07-18 | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it |
Country Status (32)
Country | Link |
---|---|
EP (2) | EP0893440A1 (xx) |
JP (1) | JP2001510824A (xx) |
KR (1) | KR100336229B1 (xx) |
CN (1) | CN1125047C (xx) |
AR (1) | AR015133A1 (xx) |
AT (1) | ATE236123T1 (xx) |
AU (1) | AU740453B2 (xx) |
BR (1) | BR9810776A (xx) |
CA (1) | CA2296637C (xx) |
CZ (1) | CZ296947B6 (xx) |
DE (1) | DE69812964T2 (xx) |
DK (1) | DK1000027T3 (xx) |
ES (1) | ES2195366T3 (xx) |
HK (1) | HK1029339A1 (xx) |
HR (1) | HRP980406A2 (xx) |
HU (1) | HUP0003198A3 (xx) |
IL (1) | IL133677A (xx) |
MA (1) | MA26523A1 (xx) |
MY (1) | MY117734A (xx) |
NO (1) | NO313588B1 (xx) |
NZ (1) | NZ502136A (xx) |
PE (1) | PE96999A1 (xx) |
PL (1) | PL191602B1 (xx) |
PT (1) | PT1000027E (xx) |
RU (1) | RU2202542C2 (xx) |
SI (1) | SI1000027T1 (xx) |
TR (1) | TR200000148T2 (xx) |
TW (1) | TW505631B (xx) |
UY (1) | UY25108A1 (xx) |
WO (1) | WO1999005105A1 (xx) |
YU (1) | YU2200A (xx) |
ZA (1) | ZA986475B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2402336C (en) * | 2000-04-03 | 2008-03-11 | F. Hoffmann-La Roche Ag | Concentrated solutions of carvedilol |
EP1655285A1 (en) * | 2000-06-28 | 2006-05-10 | Teva Pharmaceutical Industries Ltd. | Method for preparation of a crystalline form of carvedilol (form II) |
KR20080064908A (ko) * | 2000-06-28 | 2008-07-09 | 테바 파마슈티컬 인더스트리즈 리미티드 | 카르베딜올 |
DE60212130D1 (en) * | 2001-07-13 | 2006-07-20 | Smithkline Beecham Corp | Carvedilolpolymorph |
ES2298401T3 (es) | 2001-09-21 | 2008-05-16 | Egalet A/S | Dispersiones solidas de liberacion controlada de carvedilol. |
CN1308307C (zh) * | 2001-09-28 | 2007-04-04 | 弗·哈夫曼-拉罗切有限公司 | 假多晶型的卡维地洛 |
WO2003059807A2 (en) | 2002-01-15 | 2003-07-24 | Teva Pharmaceutical Industries Ltd. | Crystalline solids of carvedilol and processes for their preparation |
AU2003231283A1 (en) * | 2002-04-30 | 2003-11-17 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
US20050261355A1 (en) | 2002-06-27 | 2005-11-24 | Sb Pharmco Puerto Rico Inc., | Carvedilol hydobromide |
US7268156B2 (en) * | 2002-06-27 | 2007-09-11 | Sb Pharmco Puerto Rico Inc. | Carvedilol phosphate salts and/or solvates thereof, corresponding compositions and/or methods of treatment |
US20040151772A1 (en) | 2002-11-08 | 2004-08-05 | Egalet A/S | Controlled release carvedilol compositions |
ATE495732T1 (de) | 2003-03-26 | 2011-02-15 | Egalet As | Morphin-system mit kontrollierter freisetzung |
WO2004094378A1 (en) * | 2003-04-21 | 2004-11-04 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
SI21616A (sl) * | 2003-09-02 | 2005-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove kristalne oblike karvedilola |
US7750036B2 (en) | 2003-11-25 | 2010-07-06 | Sb Pharmco Puerto Rico Inc. | Carvedilol salts, corresponding compositions, methods of delivery and/or treatment |
EP1838670B1 (en) * | 2004-12-09 | 2009-10-14 | ZaCh System S.p.A. | Process for the preparation of carvedilol and its enantiomers |
WO2006135757A1 (en) * | 2005-06-09 | 2006-12-21 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of carvedilol and processes for their preparation |
WO2008002683A2 (en) | 2006-06-28 | 2008-01-03 | Teva Pharmaceutical Industries Ltd. | Polymorphous forms of carvedilol phosphate |
US20080249317A1 (en) * | 2007-04-04 | 2008-10-09 | Apotex Inc. | Novel amorphous form of carvedilol phosphate and processes for the preparation thereof |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3319027A1 (de) * | 1983-05-26 | 1984-11-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten |
-
1997
- 1997-07-22 EP EP97112491A patent/EP0893440A1/en not_active Withdrawn
-
1998
- 1998-07-15 MY MYPI98003245A patent/MY117734A/en unknown
- 1998-07-15 PE PE1998000626A patent/PE96999A1/es not_active Application Discontinuation
- 1998-07-18 JP JP2000504104A patent/JP2001510824A/ja active Pending
- 1998-07-18 CZ CZ20000221A patent/CZ296947B6/cs not_active IP Right Cessation
- 1998-07-18 BR BR9810776-3A patent/BR9810776A/pt not_active Application Discontinuation
- 1998-07-18 WO PCT/EP1998/004475 patent/WO1999005105A1/en active IP Right Grant
- 1998-07-18 KR KR1020007000667A patent/KR100336229B1/ko not_active IP Right Cessation
- 1998-07-18 AT AT98937576T patent/ATE236123T1/de not_active IP Right Cessation
- 1998-07-18 DE DE69812964T patent/DE69812964T2/de not_active Expired - Fee Related
- 1998-07-18 YU YU2200A patent/YU2200A/sh unknown
- 1998-07-18 PT PT98937576T patent/PT1000027E/pt unknown
- 1998-07-18 NZ NZ502136A patent/NZ502136A/en unknown
- 1998-07-18 CN CN98807436A patent/CN1125047C/zh not_active Expired - Fee Related
- 1998-07-18 CA CA002296637A patent/CA2296637C/en not_active Expired - Fee Related
- 1998-07-18 EP EP98937576A patent/EP1000027B1/en not_active Expired - Lifetime
- 1998-07-18 ES ES98937576T patent/ES2195366T3/es not_active Expired - Lifetime
- 1998-07-18 AU AU86319/98A patent/AU740453B2/en not_active Ceased
- 1998-07-18 PL PL338432A patent/PL191602B1/pl unknown
- 1998-07-18 DK DK98937576T patent/DK1000027T3/da active
- 1998-07-18 TW TW087111738A patent/TW505631B/zh not_active IP Right Cessation
- 1998-07-18 RU RU2000103033/04A patent/RU2202542C2/ru not_active IP Right Cessation
- 1998-07-18 TR TR2000/00148T patent/TR200000148T2/xx unknown
- 1998-07-18 HU HU0003198A patent/HUP0003198A3/hu unknown
- 1998-07-18 SI SI9830442T patent/SI1000027T1/xx unknown
- 1998-07-18 IL IL13367798A patent/IL133677A/en not_active IP Right Cessation
- 1998-07-20 MA MA25178A patent/MA26523A1/fr unknown
- 1998-07-21 AR ARP980103547A patent/AR015133A1/es unknown
- 1998-07-21 ZA ZA9806475A patent/ZA986475B/xx unknown
- 1998-07-22 UY UY25108A patent/UY25108A1/es not_active IP Right Cessation
- 1998-07-22 HR HR97112491.2A patent/HRP980406A2/hr not_active Application Discontinuation
-
2000
- 2000-01-21 NO NO20000301A patent/NO313588B1/no unknown
-
2001
- 2001-01-02 HK HK01100012A patent/HK1029339A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1000027T1 (en) | Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it | |
HUP0100723A3 (en) | Indole derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0203257A3 (en) | Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them | |
HUP0001943A3 (en) | Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
HUP0100225A3 (en) | Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them | |
IL120699A0 (en) | Indole derivatives and pharmaceutical compositions containing them | |
HUP9802422A3 (en) | Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0200309A3 (en) | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them | |
HUP0002830A3 (en) | Indole and 2,3-dihydroindole derivatives, their preparation, use, and pharmaceutical compositions containing them | |
HUP0000851A3 (en) | Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
HK1074163A1 (en) | Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them | |
HUP0002853A3 (en) | 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them | |
HUP9802121A3 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0003053A3 (en) | Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them | |
HUP0100785A3 (en) | Indole derivatives, process for producing them and pharmaceutical compositions containing them | |
HUP0004294A3 (en) | Indole derivatives, pharmaceutical compositions containing them and process for producing them | |
HUP0001773A3 (en) | Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them | |
EE04778B1 (et) | Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
HUP0004546A3 (en) | N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them | |
AU8031598A (en) | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0002777A3 (en) | Fused thiazolobenzoheterocyclic derivatives, process for their preparation and pharmaceutical compositions containing same | |
HUP0003104A3 (en) | Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
HUP0000854A3 (en) | 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine derivatives, pharmaceutical compositions containing them and process for the preparation of both | |
HUP0003463A3 (en) | Piperidinylmethyloxazolidinone derivative, process for its preparation pharmaceutical compositions containing it and use thereof |